Takip et
Erika Augustine
Erika Augustine
Associate Chief Science Officer, Kennedy Krieger Institute
kennedykrieger.org üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Patient-customized oligonucleotide therapy for a rare genetic disease
J Kim, C Hu, C Moufawad El Achkar, LE Black, J Douville, A Larson, ...
New England Journal of Medicine 381 (17), 1644-1652, 2019
6252019
Clinical trials in rare disease: challenges and opportunities
EF Augustine, HR Adams, JW Mink
Journal of child neurology 28 (9), 1142-1150, 2013
2542013
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial
K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ...
Jama 313 (6), 584-593, 2015
1852015
Classification and natural history of the neuronal ceroid lipofuscinoses
JW Mink, EF Augustine, HR Adams, FJ Marshall, JM Kwon
Journal of child neurology 28 (9), 1101-1105, 2013
1472013
Masturbation in infancy and early childhood presenting as a movement disorder: 12 cases and a review of the literature
ML Yang, E Fullwood, J Goldstein, JW Mink
Pediatrics 116 (6), 1427-1432, 2005
1472005
Efficacy of nilotinib in patients with moderately advanced Parkinson disease: a randomized clinical trial
T Simuni, B Fiske, K Merchant, CS Coffey, E Klingner, C Caspell-Garcia, ...
JAMA neurology 78 (3), 312-320, 2021
1262021
Sex differences in clinical features of early, treated Parkinson’s disease
EF Augustine, A Pérez, R Dhall, CC Umeh, A Videnovic, F Cambi, ...
PloS one 10 (7), e0133002, 2015
792015
Females experience a more severe disease course in Batten disease
J Cialone, H Adams, EF Augustine, FJ Marshall, JM Kwon, N Newhouse, ...
Journal of inherited metabolic disease 35, 549-555, 2012
742012
Design innovations and baseline findings in a long‐term Parkinson's trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson's Disease …
JJ Elm, NINDS NET‐PD Investigators
Movement Disorders 27 (12), 1513-1521, 2012
672012
Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease)
JM Kwon, H Adams, PG Rothberg, EF Augustine, FJ Marshall, ...
Neurology 77 (20), 1801-1807, 2011
652011
Delineation of the movement disorders associated with FOXG1 mutations
A Papandreou, RB Schneider, EF Augustine, J Ng, K Mankad, E Meyer, ...
Neurology 86 (19), 1794-1800, 2016
642016
Suicidal thoughts and behaviors in children and adolescents with chronic tic disorders
EA Storch, CE Hanks, JW Mink, JF McGuire, HR Adams, EF Augustine, ...
Depression and anxiety 32 (10), 744-753, 2015
622015
Deep phenotyping of Parkinson’s disease
ER Dorsey, L Omberg, E Waddell, JL Adams, R Adams, MR Ali, ...
Journal of Parkinson’s Disease 10 (3), 855-873, 2020
542020
Neurobehavioral features and natural history of juvenile neuronal ceroid lipofuscinosis (Batten disease)
HR Adams, JW Mink, University of Rochester Batten Center Study Group
Journal of child neurology 28 (9), 1128-1136, 2013
532013
Malignant melanoma in early‐treated Parkinson's disease: the NET‐PD trial
R Constantinescu, J Elm, P Auinger, S Sharma, EF Augustine, L Khadim, ...
Movement Disorders 29 (2), 263-265, 2014
392014
Tic disorders are associated with lower child and parent quality of life and worse family functioning
J Vermilion, E Augustine, HR Adams, A Vierhile, AB Lewin, A Thatcher, ...
Pediatric neurology 105, 48-54, 2020
372020
Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis
EF Augustine, HR Adams, CA Beck, A Vierhile, J Kwon, PG Rothberg, ...
Developmental Medicine & Child Neurology 57 (4), 366-371, 2015
352015
Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease)
HR Adams, CA Beck, E Levy, R Jordan, JM Kwon, FJ Marshall, A Vierhile, ...
Developmental Medicine & Child Neurology 52 (7), 637-643, 2010
352010
A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor–RPE interface
C Tang, J Han, S Dalvi, K Manian, L Winschel, S Volland, CA Soto, ...
Communications biology 4 (1), 161, 2021
342021
Short-term administration of mycophenolate is well-tolerated in CLN3 disease (juvenile neuronal ceroid lipofuscinosis)
EF Augustine, CA Beck, HR Adams, S Defendorf, A Vierhile, D Timm, ...
JIMD Reports, Volume 43, 117-124, 2019
332019
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20